bpc-157 and tb4 TB-500 Peptide Therapy BPC-157 / TB-500 (Tβ4) Blend

Optimized Dosing Protocol for Fat Cell Targeting Standard Injection Protocol: Starting dose: 250 mcg per day (subcutaneous injection) Target dose: 300-500 mcg per day after 1-2 weeks Advanced protocol: 500 mcg per day or 250 mcg twice daily (morning and early afternoon) Timing for Maximum Fat Cell Targeting: Morning fasted administration: Inject upon waking on empty stomach for maximum lipolytic activation Pre-workout timing: Administer 30-60 minutes before cardiovascular exercise to mobilize fatty acids for oxidation Twice-daily protocol: Morning dose plus early afternoon dose (avoiding evening to prevent potential sleep interference) Cycle Length: 12-16 weeks for initial assessment, with potential for extended protocols

Notes that high-dose niacin passes into breast milk and that lipid-altering doses could pose risks to nursing infants, recommending caution or avoidance of such doses during breastfeeding)

Unfortunately, no

There is also no evidence that the body forms antibodies against AOD9604 as it is similar enough in structure to HGH to avoid stimulating an immune system response

Epub 2014 May 14

Inflammopharmacology 14:214221 Brcic L, Brcic I, Staresinic M, Novinscak T, Sikiric P, Seiwerth S (2009) Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing